Corient Private Wealth LLC Acquires 67,149 Shares of Mettler-Toledo International, Inc. $MTD

Corient Private Wealth LLC boosted its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 91.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 140,267 shares of the medical instruments supplier’s stock after purchasing an additional 67,149 shares during the quarter. Corient Private Wealth LLC owned about 0.68% of Mettler-Toledo International worth $164,775,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Sound Income Strategies LLC increased its position in Mettler-Toledo International by 477.8% in the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 43 shares in the last quarter. Acadian Asset Management LLC increased its holdings in Mettler-Toledo International by 84.9% in the 1st quarter. Acadian Asset Management LLC now owns 2,513 shares of the medical instruments supplier’s stock worth $2,965,000 after acquiring an additional 1,154 shares in the last quarter. Financial Advisors Network Inc. increased its holdings in Mettler-Toledo International by 808.9% in the 1st quarter. Financial Advisors Network Inc. now owns 3,254 shares of the medical instruments supplier’s stock worth $3,843,000 after acquiring an additional 2,896 shares in the last quarter. Focus Partners Wealth raised its stake in Mettler-Toledo International by 85.6% during the 1st quarter. Focus Partners Wealth now owns 3,195 shares of the medical instruments supplier’s stock worth $3,774,000 after acquiring an additional 1,474 shares during the period. Finally, CW Advisors LLC lifted its holdings in Mettler-Toledo International by 250.3% during the first quarter. CW Advisors LLC now owns 620 shares of the medical instruments supplier’s stock valued at $737,000 after purchasing an additional 443 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Patrick Kaltenbach sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the transaction, the chief executive officer directly owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. This trade represents a 35.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Gerry Keller sold 236 shares of Mettler-Toledo International stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the sale, the insider directly owned 159 shares of the company’s stock, valued at $225,554.22. This represents a 59.75% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 19,565 shares of company stock worth $28,683,737. 0.77% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Citigroup increased their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. The Goldman Sachs Group began coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 price target on the stock. Morgan Stanley started coverage on Mettler-Toledo International in a research note on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 price objective for the company. Barclays lifted their target price on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research note on Monday, November 10th. Finally, Evercore ISI upped their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Five investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average price target of $1,424.17.

Mettler-Toledo International Stock Down 1.9%

Shares of NYSE:MTD opened at $1,394.97 on Monday. The firm has a fifty day simple moving average of $1,402.13 and a two-hundred day simple moving average of $1,293.95. The stock has a market capitalization of $28.50 billion, a P/E ratio of 34.79, a PEG ratio of 4.50 and a beta of 1.40. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The firm had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same period in the previous year, the company earned $10.21 EPS. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.